Concepts (248)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Abortion, Induced | 22 | 2025 | 93 | 6.330 |
Why?
|
| Robotics | 6 | 2025 | 43 | 2.290 |
Why?
|
| Pregnancy | 39 | 2024 | 1772 | 2.170 |
Why?
|
| Contraception | 7 | 2023 | 60 | 1.970 |
Why?
|
| Abortion, Spontaneous | 3 | 2022 | 27 | 1.810 |
Why?
|
| Contraception Behavior | 4 | 2020 | 33 | 1.470 |
Why?
|
| Papillomavirus Vaccines | 5 | 2024 | 174 | 1.160 |
Why?
|
| Hawaii | 24 | 2025 | 2011 | 1.070 |
Why?
|
| Postal Service | 3 | 2022 | 13 | 1.060 |
Why?
|
| Intrauterine Devices | 4 | 2020 | 19 | 1.030 |
Why?
|
| Female | 52 | 2025 | 24698 | 0.990 |
Why?
|
| Gynecology | 2 | 2025 | 35 | 0.950 |
Why?
|
| Obstetrics | 2 | 2025 | 43 | 0.930 |
Why?
|
| Abortifacient Agents | 3 | 2024 | 12 | 0.920 |
Why?
|
| Gestational Age | 8 | 2024 | 200 | 0.870 |
Why?
|
| Intention | 1 | 2025 | 108 | 0.860 |
Why?
|
| Young Adult | 25 | 2025 | 5080 | 0.860 |
Why?
|
| Adolescent | 23 | 2025 | 6081 | 0.830 |
Why?
|
| Internship and Residency | 1 | 2025 | 146 | 0.820 |
Why?
|
| Contraceptive Agents, Female | 3 | 2020 | 25 | 0.820 |
Why?
|
| Adult | 33 | 2025 | 13872 | 0.800 |
Why?
|
| Humans | 58 | 2026 | 43102 | 0.790 |
Why?
|
| Telemedicine | 3 | 2021 | 234 | 0.780 |
Why?
|
| Health Services Accessibility | 2 | 2021 | 706 | 0.780 |
Why?
|
| Uterine Hemorrhage | 4 | 2019 | 14 | 0.760 |
Why?
|
| Physicians | 2 | 2025 | 188 | 0.760 |
Why?
|
| Fetal Research | 1 | 2022 | 4 | 0.750 |
Why?
|
| Fentanyl | 1 | 2022 | 16 | 0.740 |
Why?
|
| Home Childbirth | 1 | 2022 | 1 | 0.730 |
Why?
|
| Mercury | 3 | 2024 | 39 | 0.730 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2022 | 44 | 0.700 |
Why?
|
| Qualitative Research | 6 | 2023 | 574 | 0.700 |
Why?
|
| Intrauterine Devices, Medicated | 2 | 2018 | 12 | 0.670 |
Why?
|
| Levonorgestrel | 2 | 2018 | 17 | 0.670 |
Why?
|
| Papillomavirus Infections | 4 | 2024 | 376 | 0.650 |
Why?
|
| Sexually Transmitted Diseases | 2 | 2019 | 174 | 0.640 |
Why?
|
| Pregnancy, Unplanned | 2 | 2020 | 29 | 0.630 |
Why?
|
| Fetal Blood | 3 | 2015 | 48 | 0.630 |
Why?
|
| Social Values | 2 | 2016 | 31 | 0.600 |
Why?
|
| Choice Behavior | 1 | 2020 | 93 | 0.600 |
Why?
|
| Seafood | 3 | 2024 | 26 | 0.590 |
Why?
|
| Insurance, Health | 3 | 2023 | 145 | 0.580 |
Why?
|
| Attitude to Health | 1 | 2021 | 338 | 0.570 |
Why?
|
| Condoms | 1 | 2019 | 150 | 0.570 |
Why?
|
| Insurance Coverage | 2 | 2015 | 110 | 0.550 |
Why?
|
| Laminaria | 1 | 2017 | 2 | 0.540 |
Why?
|
| Anesthesia, Obstetrical | 1 | 2017 | 8 | 0.530 |
Why?
|
| United States | 10 | 2025 | 5205 | 0.530 |
Why?
|
| Postpartum Period | 1 | 2018 | 92 | 0.520 |
Why?
|
| Reminder Systems | 1 | 2017 | 16 | 0.510 |
Why?
|
| Postnatal Care | 1 | 2017 | 16 | 0.510 |
Why?
|
| Attitude of Health Personnel | 2 | 2017 | 231 | 0.500 |
Why?
|
| Family Planning Services | 2 | 2018 | 34 | 0.500 |
Why?
|
| Pregnancy Trimester, Second | 2 | 2017 | 15 | 0.480 |
Why?
|
| Family Planning Policy | 1 | 2015 | 1 | 0.470 |
Why?
|
| Family Practice | 2 | 2016 | 60 | 0.470 |
Why?
|
| Oxytocin | 3 | 2022 | 24 | 0.460 |
Why?
|
| Health Knowledge, Attitudes, Practice | 5 | 2017 | 989 | 0.440 |
Why?
|
| Pediatrics | 1 | 2015 | 70 | 0.440 |
Why?
|
| Diabetes, Gestational | 3 | 2023 | 56 | 0.430 |
Why?
|
| Medicaid | 1 | 2015 | 143 | 0.410 |
Why?
|
| Income | 1 | 2014 | 160 | 0.400 |
Why?
|
| Double-Blind Method | 4 | 2022 | 317 | 0.370 |
Why?
|
| Misoprostol | 6 | 2022 | 27 | 0.370 |
Why?
|
| Cesarean Section | 2 | 2011 | 63 | 0.360 |
Why?
|
| Drug Delivery Systems | 2 | 2025 | 277 | 0.350 |
Why?
|
| Balloon Occlusion | 1 | 2011 | 3 | 0.350 |
Why?
|
| Dilatation and Curettage | 1 | 2011 | 4 | 0.350 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2011 | 7 | 0.350 |
Why?
|
| Feeding Behavior | 1 | 2014 | 469 | 0.320 |
Why?
|
| Oxytocics | 3 | 2019 | 8 | 0.320 |
Why?
|
| Analgesics | 2 | 2022 | 55 | 0.310 |
Why?
|
| Logistic Models | 4 | 2022 | 1009 | 0.310 |
Why?
|
| Ultrasonography, Prenatal | 3 | 2024 | 40 | 0.290 |
Why?
|
| Diet | 1 | 2014 | 826 | 0.280 |
Why?
|
| Selenium | 2 | 2024 | 155 | 0.280 |
Why?
|
| Blood Loss, Surgical | 2 | 2018 | 15 | 0.270 |
Why?
|
| Mifepristone | 3 | 2022 | 34 | 0.260 |
Why?
|
| Male | 15 | 2025 | 23409 | 0.260 |
Why?
|
| Pain | 2 | 2022 | 290 | 0.260 |
Why?
|
| Patient Satisfaction | 2 | 2017 | 165 | 0.250 |
Why?
|
| Abortifacient Agents, Nonsteroidal | 3 | 2021 | 10 | 0.240 |
Why?
|
| Pregnancy Trimester, First | 2 | 2024 | 20 | 0.240 |
Why?
|
| Ibuprofen | 2 | 2022 | 34 | 0.230 |
Why?
|
| Students, Medical | 2 | 2018 | 158 | 0.230 |
Why?
|
| Health Priorities | 1 | 2025 | 25 | 0.230 |
Why?
|
| Rh-Hr Blood-Group System | 1 | 2025 | 6 | 0.220 |
Why?
|
| Child | 4 | 2024 | 3443 | 0.220 |
Why?
|
| Magnetics | 2 | 2022 | 43 | 0.220 |
Why?
|
| Pregnancy in Adolescence | 2 | 2016 | 34 | 0.210 |
Why?
|
| Women's Health | 1 | 2025 | 160 | 0.210 |
Why?
|
| Physical Phenomena | 1 | 2023 | 3 | 0.200 |
Why?
|
| Heating | 1 | 2023 | 6 | 0.200 |
Why?
|
| Treatment Outcome | 3 | 2024 | 1604 | 0.200 |
Why?
|
| Body Temperature Regulation | 1 | 2023 | 8 | 0.200 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2020 | 497 | 0.200 |
Why?
|
| Elastomers | 1 | 2022 | 3 | 0.190 |
Why?
|
| Motion | 1 | 2022 | 31 | 0.190 |
Why?
|
| Fetal Tissue Transplantation | 1 | 2022 | 4 | 0.190 |
Why?
|
| Aborted Fetus | 1 | 2022 | 5 | 0.190 |
Why?
|
| Pelvic Pain | 1 | 2022 | 10 | 0.190 |
Why?
|
| Parturition | 1 | 2022 | 22 | 0.180 |
Why?
|
| Intraoperative Complications | 2 | 2019 | 20 | 0.180 |
Why?
|
| Patient-Centered Care | 1 | 2022 | 75 | 0.180 |
Why?
|
| Abortifacient Agents, Steroidal | 1 | 2021 | 3 | 0.170 |
Why?
|
| Drug and Narcotic Control | 1 | 2021 | 12 | 0.170 |
Why?
|
| United States Food and Drug Administration | 1 | 2021 | 29 | 0.170 |
Why?
|
| Confidentiality | 1 | 2021 | 29 | 0.170 |
Why?
|
| Contraceptive Agents | 1 | 2020 | 13 | 0.170 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2024 | 587 | 0.170 |
Why?
|
| Infant, Newborn | 2 | 2022 | 972 | 0.160 |
Why?
|
| Sterilization, Tubal | 1 | 2020 | 6 | 0.160 |
Why?
|
| Case-Control Studies | 2 | 2022 | 1285 | 0.160 |
Why?
|
| Animals | 8 | 2025 | 16992 | 0.160 |
Why?
|
| Macrophages | 1 | 2024 | 529 | 0.160 |
Why?
|
| Postoperative Complications | 2 | 2019 | 263 | 0.160 |
Why?
|
| Electric Capacitance | 1 | 2019 | 7 | 0.160 |
Why?
|
| Textiles | 1 | 2019 | 7 | 0.160 |
Why?
|
| Foot | 1 | 2019 | 10 | 0.150 |
Why?
|
| Data Collection | 1 | 2019 | 210 | 0.150 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2018 | 27 | 0.150 |
Why?
|
| Lab-On-A-Chip Devices | 1 | 2019 | 38 | 0.140 |
Why?
|
| Communication | 2 | 2017 | 210 | 0.140 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2018 | 33 | 0.140 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2019 | 157 | 0.140 |
Why?
|
| Middle Aged | 5 | 2025 | 12222 | 0.140 |
Why?
|
| Cross-Sectional Studies | 5 | 2025 | 3156 | 0.140 |
Why?
|
| Hemostatics | 1 | 2018 | 10 | 0.140 |
Why?
|
| Neurons | 1 | 2025 | 1263 | 0.140 |
Why?
|
| Sodium Bicarbonate | 1 | 2017 | 7 | 0.130 |
Why?
|
| Health Personnel | 1 | 2020 | 277 | 0.130 |
Why?
|
| Lidocaine | 1 | 2017 | 16 | 0.130 |
Why?
|
| Retrospective Studies | 6 | 2024 | 2544 | 0.130 |
Why?
|
| Dilatation | 1 | 2017 | 4 | 0.130 |
Why?
|
| Age Factors | 2 | 2018 | 1154 | 0.130 |
Why?
|
| Self-Examination | 1 | 2017 | 9 | 0.130 |
Why?
|
| Delivery, Obstetric | 1 | 2017 | 48 | 0.130 |
Why?
|
| Decision Making | 1 | 2019 | 249 | 0.130 |
Why?
|
| Feasibility Studies | 1 | 2018 | 259 | 0.130 |
Why?
|
| Pamphlets | 1 | 2016 | 27 | 0.120 |
Why?
|
| Sexual Partners | 1 | 2019 | 326 | 0.120 |
Why?
|
| Pain Measurement | 1 | 2017 | 183 | 0.120 |
Why?
|
| Counseling | 3 | 2023 | 138 | 0.120 |
Why?
|
| Population Groups | 1 | 2016 | 59 | 0.120 |
Why?
|
| Parents | 2 | 2016 | 370 | 0.120 |
Why?
|
| Trust | 1 | 2017 | 167 | 0.120 |
Why?
|
| Electronic Health Records | 1 | 2017 | 108 | 0.120 |
Why?
|
| Family Relations | 1 | 2015 | 46 | 0.120 |
Why?
|
| Phantoms, Imaging | 2 | 2026 | 28 | 0.110 |
Why?
|
| Pilot Projects | 1 | 2018 | 760 | 0.110 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 1067 | 0.110 |
Why?
|
| Family Characteristics | 1 | 2015 | 126 | 0.110 |
Why?
|
| Philippines | 1 | 2014 | 81 | 0.110 |
Why?
|
| Pacific Islands | 1 | 2014 | 123 | 0.100 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2022 | 760 | 0.100 |
Why?
|
| Focus Groups | 1 | 2015 | 423 | 0.100 |
Why?
|
| Japan | 1 | 2014 | 348 | 0.100 |
Why?
|
| Overweight | 1 | 2015 | 249 | 0.100 |
Why?
|
| Selenoproteins | 1 | 2015 | 155 | 0.100 |
Why?
|
| Vaccination | 1 | 2015 | 355 | 0.100 |
Why?
|
| Residence Characteristics | 1 | 2015 | 363 | 0.090 |
Why?
|
| Social Support | 1 | 2015 | 445 | 0.090 |
Why?
|
| Obesity | 2 | 2017 | 1151 | 0.090 |
Why?
|
| Vitamin D Deficiency | 1 | 2013 | 107 | 0.090 |
Why?
|
| Vitamin D | 1 | 2013 | 196 | 0.080 |
Why?
|
| Antineoplastic Agents | 1 | 2019 | 1019 | 0.080 |
Why?
|
| Health Promotion | 1 | 2016 | 704 | 0.080 |
Why?
|
| Pregnancy Outcome | 1 | 2010 | 102 | 0.080 |
Why?
|
| Fishes | 2 | 2024 | 73 | 0.080 |
Why?
|
| Placenta | 2 | 2024 | 117 | 0.070 |
Why?
|
| Mice | 3 | 2025 | 6644 | 0.070 |
Why?
|
| Neoplasms | 1 | 2018 | 1377 | 0.070 |
Why?
|
| Electromagnetic Fields | 1 | 2025 | 10 | 0.060 |
Why?
|
| Photochemotherapy | 1 | 2026 | 43 | 0.060 |
Why?
|
| Blood Grouping and Crossmatching | 1 | 2025 | 5 | 0.060 |
Why?
|
| Eligibility Determination | 1 | 2024 | 9 | 0.050 |
Why?
|
| Pregnancy, Ectopic | 1 | 2024 | 15 | 0.050 |
Why?
|
| Abortion, Legal | 1 | 2023 | 6 | 0.050 |
Why?
|
| Flowers | 1 | 2023 | 20 | 0.050 |
Why?
|
| Selenocysteine | 1 | 2024 | 58 | 0.050 |
Why?
|
| Asia | 1 | 2023 | 98 | 0.050 |
Why?
|
| Pharmacists | 1 | 2024 | 61 | 0.050 |
Why?
|
| Cysteine | 1 | 2024 | 103 | 0.050 |
Why?
|
| Gender Identity | 1 | 2024 | 117 | 0.050 |
Why?
|
| Holistic Health | 1 | 2023 | 13 | 0.050 |
Why?
|
| Electricity | 1 | 2022 | 12 | 0.050 |
Why?
|
| Calcium | 1 | 2025 | 491 | 0.050 |
Why?
|
| Needs Assessment | 1 | 2024 | 178 | 0.050 |
Why?
|
| Oxycodone | 1 | 2022 | 7 | 0.050 |
Why?
|
| Acetaminophen | 1 | 2022 | 30 | 0.050 |
Why?
|
| Risk Reduction Behavior | 1 | 2023 | 138 | 0.040 |
Why?
|
| Locomotion | 1 | 2022 | 105 | 0.040 |
Why?
|
| Infusion Pumps, Implantable | 1 | 2021 | 4 | 0.040 |
Why?
|
| Microtechnology | 1 | 2021 | 5 | 0.040 |
Why?
|
| Aftercare | 1 | 2021 | 22 | 0.040 |
Why?
|
| Biomimetics | 1 | 2021 | 15 | 0.040 |
Why?
|
| Biomimetic Materials | 1 | 2021 | 24 | 0.040 |
Why?
|
| Equipment Design | 1 | 2021 | 145 | 0.040 |
Why?
|
| Contraceptives, Oral, Combined | 1 | 2020 | 12 | 0.040 |
Why?
|
| Analgesics, Opioid | 1 | 2022 | 252 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2020 | 368 | 0.040 |
Why?
|
| Blood Volume | 1 | 2019 | 6 | 0.040 |
Why?
|
| Reference Values | 1 | 2019 | 211 | 0.040 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2018 | 25 | 0.040 |
Why?
|
| Methylergonovine | 1 | 2018 | 3 | 0.040 |
Why?
|
| Vasopressins | 1 | 2018 | 12 | 0.040 |
Why?
|
| Biomedical Research | 1 | 2023 | 502 | 0.030 |
Why?
|
| Minority Groups | 1 | 2023 | 690 | 0.030 |
Why?
|
| Patient Care Planning | 1 | 2017 | 18 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2019 | 341 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2019 | 575 | 0.030 |
Why?
|
| Vacuum Extraction, Obstetrical | 1 | 2017 | 5 | 0.030 |
Why?
|
| Parity | 1 | 2017 | 59 | 0.030 |
Why?
|
| Education, Medical, Graduate | 1 | 2017 | 61 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2024 | 2676 | 0.030 |
Why?
|
| Prevalence | 2 | 2013 | 1612 | 0.030 |
Why?
|
| Physician-Patient Relations | 1 | 2017 | 148 | 0.030 |
Why?
|
| Sex Education | 1 | 2016 | 36 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 1063 | 0.030 |
Why?
|
| Health Care Surveys | 1 | 2016 | 152 | 0.030 |
Why?
|
| Community Networks | 1 | 2016 | 107 | 0.030 |
Why?
|
| Health Surveys | 1 | 2017 | 405 | 0.030 |
Why?
|
| Program Development | 1 | 2016 | 240 | 0.030 |
Why?
|
| Time Factors | 1 | 2019 | 1857 | 0.030 |
Why?
|
| Peer Group | 1 | 2016 | 177 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2016 | 359 | 0.030 |
Why?
|
| Adolescent Behavior | 1 | 2016 | 281 | 0.030 |
Why?
|
| Nonlinear Dynamics | 1 | 2013 | 35 | 0.020 |
Why?
|
| Health Education | 1 | 2016 | 363 | 0.020 |
Why?
|
| Lactation | 1 | 2013 | 44 | 0.020 |
Why?
|
| Sunlight | 1 | 2013 | 48 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2015 | 883 | 0.020 |
Why?
|
| Seasons | 1 | 2013 | 139 | 0.020 |
Why?
|
| Sexual Behavior | 1 | 2016 | 638 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 236 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2013 | 213 | 0.020 |
Why?
|
| Maternal Age | 1 | 2010 | 33 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2015 | 1271 | 0.020 |
Why?
|
| Micronesia | 1 | 2010 | 90 | 0.020 |
Why?
|
| Birth Weight | 1 | 2010 | 95 | 0.020 |
Why?
|
| Age Distribution | 1 | 2010 | 249 | 0.020 |
Why?
|
| Infant | 1 | 2013 | 1175 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2013 | 1234 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2013 | 1600 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2010 | 389 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2010 | 925 | 0.010 |
Why?
|
| Aged | 1 | 2016 | 8214 | 0.010 |
Why?
|
| Risk Factors | 1 | 2010 | 3994 | 0.010 |
Why?
|